Lisata Therapeutics (LSTA) Competitors $2.74 -0.19 (-6.48%) Closing price 04:00 PM EasternExtended Trading$2.77 +0.03 (+1.09%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LSTA vs. TNYA, BYSI, OPTN, HURA, COYA, XBIT, MCRB, OCX, VIRI, and ORMPShould you be buying Lisata Therapeutics stock or one of its competitors? The main competitors of Lisata Therapeutics include Tenaya Therapeutics (TNYA), BeyondSpring (BYSI), OptiNose (OPTN), TuHURA Biosciences (HURA), Coya Therapeutics (COYA), XBiotech (XBIT), Seres Therapeutics (MCRB), OncoCyte (OCX), Virios Therapeutics (VIRI), and Oramed Pharmaceuticals (ORMP). These companies are all part of the "pharmaceutical products" industry. Lisata Therapeutics vs. Its Competitors Tenaya Therapeutics BeyondSpring OptiNose TuHURA Biosciences Coya Therapeutics XBiotech Seres Therapeutics OncoCyte Virios Therapeutics Oramed Pharmaceuticals Tenaya Therapeutics (NASDAQ:TNYA) and Lisata Therapeutics (NASDAQ:LSTA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Does the media refer more to TNYA or LSTA? In the previous week, Tenaya Therapeutics had 5 more articles in the media than Lisata Therapeutics. MarketBeat recorded 6 mentions for Tenaya Therapeutics and 1 mentions for Lisata Therapeutics. Tenaya Therapeutics' average media sentiment score of 0.40 beat Lisata Therapeutics' score of 0.00 indicating that Tenaya Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Tenaya Therapeutics Neutral Lisata Therapeutics Neutral Do institutionals and insiders believe in TNYA or LSTA? 90.5% of Tenaya Therapeutics shares are held by institutional investors. Comparatively, 8.9% of Lisata Therapeutics shares are held by institutional investors. 48.7% of Tenaya Therapeutics shares are held by insiders. Comparatively, 9.6% of Lisata Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is TNYA or LSTA more profitable? Lisata Therapeutics' return on equity of -61.37% beat Tenaya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tenaya TherapeuticsN/A -92.20% -74.53% Lisata Therapeutics N/A -61.37%-53.35% Do analysts prefer TNYA or LSTA? Tenaya Therapeutics presently has a consensus target price of $6.25, indicating a potential upside of 808.69%. Lisata Therapeutics has a consensus target price of $15.00, indicating a potential upside of 447.45%. Given Tenaya Therapeutics' higher possible upside, equities analysts clearly believe Tenaya Therapeutics is more favorable than Lisata Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenaya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Lisata Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings & valuation, TNYA or LSTA? Lisata Therapeutics has higher revenue and earnings than Tenaya Therapeutics. Lisata Therapeutics is trading at a lower price-to-earnings ratio than Tenaya Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenaya TherapeuticsN/AN/A-$111.13M-$1.16-0.59Lisata Therapeutics$1M23.62-$19.99M-$2.30-1.19 Which has more volatility & risk, TNYA or LSTA? Tenaya Therapeutics has a beta of 3, indicating that its stock price is 200% more volatile than the S&P 500. Comparatively, Lisata Therapeutics has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. SummaryTenaya Therapeutics beats Lisata Therapeutics on 8 of the 12 factors compared between the two stocks. Get Lisata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LSTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LSTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LSTA vs. The Competition Export to ExcelMetricLisata TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.23M$2.96B$5.56B$9.04BDividend YieldN/A2.42%5.25%4.03%P/E RatioN/A8.0519.5820.23Price / Sales23.62296.11442.27127.79Price / CashN/A42.7337.5058.41Price / Book0.797.748.085.60Net Income-$19.99M-$54.96M$3.16B$248.43M7 Day Performance3.79%6.04%3.77%5.15%1 Month Performance6.20%4.47%3.90%7.62%1 Year Performance-19.65%6.12%34.22%21.56% Lisata Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LSTALisata Therapeutics2.4897 of 5 stars$2.74-6.5%$15.00+447.4%-14.1%$25.23M$1M0.0030Positive NewsTNYATenaya Therapeutics3.4209 of 5 stars$0.61-0.4%$6.25+926.3%-77.6%$99.07MN/A-0.53110BYSIBeyondSpringN/A$2.46+4.5%N/A-0.4%$98.98MN/A0.0080Positive NewsOPTNOptiNose0.7508 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190HURATuHURA Biosciences1.2623 of 5 stars$2.22-0.7%$12.67+471.9%N/A$96.31MN/A0.00N/ACOYACoya Therapeutics2.3415 of 5 stars$5.73-0.3%$16.67+190.9%-5.9%$95.86M$3.55M-5.366News CoverageAnalyst ForecastXBITXBiotech0.4767 of 5 stars$3.03+1.9%N/A-48.5%$92.23M$4.01M-2.34100MCRBSeres Therapeutics3.5781 of 5 stars$10.53-5.2%$73.67+599.6%-39.3%$91.93M$126.32M-2.29330Positive NewsOCXOncoCyte2.0393 of 5 stars$3.18+16.3%$6.06+90.9%+6.2%$90.80M$3.84M-0.90120VIRIVirios TherapeuticsN/A$4.71-1.3%$5.00+6.2%+1,754.4%$90.71MN/A-17.445ORMPOramed Pharmaceuticals0.2858 of 5 stars$2.19-2.9%N/A-13.2%$89.26M$2M-4.9710 Related Companies and Tools Related Companies Tenaya Therapeutics Competitors BeyondSpring Competitors OptiNose Competitors TuHURA Biosciences Competitors Coya Therapeutics Competitors XBiotech Competitors Seres Therapeutics Competitors OncoCyte Competitors Virios Therapeutics Competitors Oramed Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LSTA) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lisata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
